[1]
|
Binder, H.J. and Donowitz, M. (1975) A new look at laxative action. Gastroenterology, 69, 1001-1005.
|
[2]
|
Hervé, S., Savoye, G., Behbahani, A., Leroi, A.M., Denis, P. and Ducrotté, P. (2004) Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterology and Motility, 16, 397-402. doi:10.1111/j.1365-2982.2004.00535.x
|
[3]
|
Bundesvereinigung Deutscher Apothekerverbande, 2011.
http://www.abda.de/ 52+B6JmNIYXNoPTMyMjllYmNhMTQmdHhfdHRuZXdzW2JhY2tQaWRd PTI0JnR4X3R0bmV3c1twb2ludGVyXT01JnR4X3R0bmV3c1t0dF9uZXdzXT0xMzU4.html
|
[4]
|
ADRAC (2002) Electrolyte disturbances with sodium picosulfate bowel cleansing products. Australian Adverse Drug Reactions Bulletin, 21, 1-4.
|
[5]
|
(1997) Consumer reports complete drug reference, 981-988.
|
[6]
|
Fruit-Eze, Inc. Laxative Warnings, Side Effects & Contraindications Reported in Medical Literature.
http://web.pdx.edu/~sujata/FruitEze/education/laxative/medical_warnings.html#1
|
[7]
|
Bytzer, P., Stokholm, M., Andersen, I., Klitgaard, N.A. and Schaffalitzky de Muckadell, O.B. (1989) Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: A cost benefit analysis of a screening procedure. Gut, 30, 1379-1384.
doi:10.1136/gut.30.10.1379
|
[8]
|
Cummings, J.H., Sladen, G.E., James, O.F.W., Sarner, M. and Misiewicz, J.J. (1974) Laxative-induced diarrhoea: A continuing clinical problem. British Medical Journal, 1, 537. doi:10.1136/bmj.1.5907.537
|
[9]
|
Read, N.W., Krejs, G.J. and Read, M.G. (1980) Chronic diarrhea of unknown origin. Gastroenterology, 78, 264-271.
|
[10]
|
Ruidisch, M.H., Hutt, H.-J. and Konig, E. (1994) Laxanzien-langzeittherapie mit bisacodyl. Wirksamkeit und vertraglichkeit bei patienten mit rückenmarkverletzungen. Arztliche Forschung, 41, 3-8.
|
[11]
|
Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F. and Spiller, R.C. (2006) Functional bowel disorders. Gastroenterology, 130, 1480-1491.
doi:10.1053/j.gastro.2005.11.061
|
[12]
|
Thompson, W.G., Longstreth, G.F., Drossman, D.A., Heaton, K.W., Irvine, E.J. and Müller-Lissner, S.A. (1999) Functional bowel disorders and functional abdominal pain. Gut, 45, II43-II47. doi:10.1136/gut.45.2008.ii43
|
[13]
|
Kienzle-Horn, S., Vix, J.M., Schuijt, C., Peil, H., Jordan, C.C. and Kamm, M.A. (2007) Comparison of bisacodyl and sodium picosulfate in the treatment of chronic constipation. Current Medical Research and Opinion, 23, 891-899. doi:10.1185/030079907X178865
|
[14]
|
Kamm, M.A., Mueller-Lissner, S., Wald, A., Richter, E., Swallow, R. and Gessner, U. (2011) Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clinical Gastroenterology and Hepatology, 9, 577-583. doi:10.1016/j.cgh.2011.03.026
|
[15]
|
Müller-Lissner, S.A., Kamm, M.A., Scarpignato, C. and Wald, A. (2005) Myths and misconceptions about chronic constipation. American Journal of Gastroenterology, 100, 232-242. doi:10.1111/j.1572-0241.2005.40885.x
|
[16]
|
Müller-Lissner, S.A. (1996) What has happened to the cathartic colon? Gut, 39, 486-488.
doi:10.1136/gut.39.3.486
|
[17]
|
Kienzle-Horn, S., Vix, J.M., Schuijt, C., Peil, H., Jordan, C.C. and Kamm, M.A. (2006) Efficacy and safety of bisacodyl in the acute treatment of constipation: A doubleblind, randomized, placebo-controlled study. Alimentary Pharmacology & Therapeutics, 23, 1479-1488.
doi:10.1111/j.1365-2036.2006.02903.x
|
[18]
|
Hinkel, U., Schuijt, C. and Erckenbrecht, J. (2008) OTC laxative use of sodium picosulfate—Results of a pharmacy-based patient survey (cohort study). International Journal of Clinical Pharmacology and Therapeutics, 46, 89-95.
|